01 1Natco Pharma
01 1SUGAMMADEX SODIUM
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-07-31
Pay. Date : 2019-07-02
DMF Number : 33921
Submission : 2019-07-08
Status : Active
Type : II
20
Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SUGAMMADEX SODIUM, with a corresponding US DMF Number 33921.
Remarkably, this DMF maintains an Active status since its submission on July 08, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 31, 2019, and payment made on July 02, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
